GST-RT-3$90.00Select options
RETA
GST-RT-3
Retatrutide is a synthetic peptide designed to interact with multiple metabolic receptor pathways, including GLP-1, GIP, and glucagon receptors.
High-Purity Research Materials
$90.00
Research Use Only. Not for human consumption. Not intended to diagnose, treat, cure or prevent any disease.
Ready-dose kit
Prepped, packed, and ready to dose your labrat straight out of the box.
COA
Independently tested and verified COA documentation.
Reconstitution
Each peptide vial comes with a free reconstitution solution.
syringes
No need to hunt down supplies—complimentary syringes are included with your order.
| GST-RT-3 | |
|---|---|
| Product Name: | RETA |
| Classification: | Research Use |
| Form: | Lyophilized Powder |
| Storage: | Store Refrigerated |
| Intended Use: | Laboratory / Scientific Research |
| Documentation: | AUR |
Product information
Observed Clinical Trial Benefits
Disclaimer: Potential benefits are based on ongoing research and are not established medical claims. For research use only; not for human consumption. Not evaluated by the FDA.
Weight Reduction
Phase 3 participants achieved substantial average body-weight reductions.
Blood Sugar Control
In people with type 2 diabetes, retatrutide produced substantial reductions in A1C.
Reduced Waist Circumference
Clinical studies showed meaningful decreases in waist measurements.
Reduced Sleep Apnea
Phase 3 results reported large reductions in apnea/hypopnea events.
Triple-Receptor Activity
Retatrutide simultaneously activates GLP-1, GIP, and glucagon receptors, a mechanism being studied for weight and metabolic effects.
Reduced Knee Osteoarthritis Pain
Trial participants with obesity and knee osteoarthritis experienced meaningful pain improvement.